Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Virgili, Gianni ^a   Menchini, Francesca ^b   Murro, Vittoria ^a   Peluso, Emanuela ^c   Rosa, Francesca ^c   Casazza, Giovanni ^d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; EYE EXAMINATION; HUMAN; MEDICAL SPECIALIST; OPTICAL COHERENCE TOMOGRAPHY; REFERENCE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD; SYSTEMATIC REVIEW;

EID: 77950121972     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008081     Document Type: Review

References (32)

1. Aiello 1998 Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris III FL. Diabetic retinopathy. Diabetes Care 1998;21(1):143-56.
2. Aiello 2003 Aiello ML. Perspectives of diabetic retinopathy. American Journal of Ophthalmology 2003;136(1):122-35.
3. Bossuyt 2006 Bossuyt PM, Irwig L, Craig J, Glasziou P. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 2006; 332(7549):1089-92.
4. Browning 2004 Browning DJ, McOwen MD, Bowen RM Jr, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 2004;111(4):712-5.
5. Chan 2005 Chan A, Duker JS. A standardized method for reporting changes in macular thickening using optical coherence tomography. Archives of Ophthalmology 2005;123(7):939-43.
6. Cunningham 2005 Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, et al.Macugen Diabetic Retinopathy Study Group. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005;112(10):1747-57.
7. Deeks 2005 Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology 2005;58(9):882-93.
8. DRCR Network 2007a Diabetic Retinopathy Clinical Research Network, Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, et al.A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007;114(10):1860-7.
9. DRCR Network 2007b Diabetic Retinopathy Clinical Research Network, Krzystolik MG, Strauber SF, Aiello LP, Beck RW, Berger BB, Bressler NM, et al.Reproducibility of macular thickness and volume using zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 2007;114(8):1520-5.
10. DRS 1987 Anonymous. Indications for photocoagulation treatment of diabetic retinopathy. Diabetic Retinopathy Study Report Number 14. International Ophthalmology Clinics 1987;27(4):239-53.
11. Dukic 2003 Dukic V, Gatsonis C. Meta-analysis of diagnostic test accuracy assessment studies with varying number of thresholds. Biometrics 2003;59(4):936-46.
12. ETDRS 1985 Anonymous. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Archives of Ophthalmology 1985;103(12):1796-806.
13. Forooghian 2008 Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Investigative Ophthalmology & Visual Science 2008;49(10):4290-6.
14. Goebel 2006 Goebel W, Franke R. Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina 2006;26(1):49-57.
15. Grover 2008 Grover D, Li TJ, Chong CCW. Intravitreal steroids for macular edema in diabetes. Cochrane Database of Systematic Reviews 2008, Issue 1. [Art. No.: CD005656. DOI: 10.1002/14651858.CD005656.pub2]
16. Hee 1998 Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG,Wilkins JR, et al.Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998;105(2):360-70.
17. Javitt 1989 Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology 1989;96(2):255-64.
18. Kiernan 2009 Kiernan DF, Hariprasad SM, Chin EK, Kiernan CL, Rago J, Mieler WF. Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness. American Journal of Ophthalmology 2009;147(2):267-75.
19. King 1998 King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21(9):1414-31.
20. Kinyoun 1989 Kinyoun J, Barton F, Fisher M, Hubbard L, Aiello L, Ferris F. Detection of diabetic macular edema. Ophthalmoscopy versus photography - Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology 1989;96(6):746-51.
21. Leeflang 2008 Leeflang MM, Moons KG, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clinical Chemistry 2008;54(4):729-37.
22. Lijmer 1999 Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, Van Der Meulen JH, et al.Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282(11):1061-6.
23. NIH 1995 National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease. Diabetes in America. 2nd Edition. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1995.
24. Pewsner 2004 Pewsner D, Battaglia M, MInder C, Marx A, Bucher HC, Egger M. Ruling a diagnosis in or out with "SpPIn" and "SnNOut":a note of caution. BMJ 2004;329(7459):209-13.
25. Reitsma 2005 Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982-90.
26. Rutjes 2005 Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and two-gate designs in diagnostic accuracy studies. Clinical Chemistry 2005;51(8):1335-41.
27. Virgili 2007 Virgili G, Menchini F, Dimastrogiovanni AF, Rapizzi E, Menchini U, Bandello F, et al.Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Investigative Ophthalmology & Visual Science 2007;48(11):4963-73.
28. Whiting 2003 Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 2003;3:25.
29. Whiting 2004 Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Annals of Internal Medicine 2004;140(3):189- 202.
30. WHO 2002 World Health Organisation. The World Health Report 2002. Available at: http://www.who.int/whr/en.
31. Williams 2004 Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004;18(10):963-83.
32. Wolf-Schnurrbusch 2009 Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, Iliev ME, Frey M, Rothenbuehler SP, et al.Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Investigative Ophthalmology & Visual Science 2009;50(7):3432- 7.